The pandemic that is shaping us

Our experts

I chose to focus my work on vaccines and infectious diseases because it’s been a long-standing passion of mine. I hold a PhD in immunology, and so supporting clients who focus on innovation in this space is something that I’ve dedicated a large portion of my life to.

Partner, Chicago
Video

Achieving the impossible in vaccine innovation

Getting to work: Employers’ role in COVID-19 vaccination
Article
Getting to work: Employers’ role in COVID-19 vaccination
-
A light at the end of the tunnel: US COVID-19 vaccine administration
Article
A light at the end of the tunnel: US COVID-19 vaccine administration
-
Guarav Agrawal

I’ve always been passionate about the intersection of science, business, and patients. For more than a decade, I’ve focused on how clients can bring scientific breakthroughs more efficiently to patients.

Partner, New York
Video

Working across the COVID-19 ecosystem

Fast-forward: Will the speed of COVID-19 vaccine development reset industry norms?
Article
Fast-forward: Will the speed of COVID-19 vaccine development reset industry norms?
-
Biopharma 2020: A landmark year and a reset for the future
Article
Biopharma 2020: A landmark year and a reset for the future
-
Tania Holt

I’m really proud of being part of making sure that the vaccines reach everybody in the world and not just the high-income countries. It requires global collaboration and there is more to do in making this a reality.

Partner, London
Video

Seeking global solutions for a global pandemic

Africa needs vaccines. What would it take to make them here?
Article
Africa needs vaccines. What would it take to make them here?
-
The COVID-19  vaccines are here: What comes next?
Article
The COVID-19 vaccines are here: What comes next?
-

I think we’ll reflect back 20 years from now and say this was a warning sign of something bigger that can come, and there’s going to be a real catalyst that comes out of COVID-19.

Senior Partner, Chicago
Video

Catalyzing and changing our preparedness for the future

When will the COVID-19 pandemic end?
Article
When will the COVID-19 pandemic end?
-
On pins and needles: Will COVID-19 vaccines ‘save the world’?
Article
On pins and needles: Tracking COVID-19 vaccines and therapeutics
-
Michael Conway

I care about meeting people’s unmet needs. In developed countries, I've spent time working on vaccines that prevent illnesses that cause mortality in old people and in developing countries, addressing diseases affecting children.

Senior Partner, Philadelphia
Video

Changing the infectious disease landscape through vaccines

COVID-19 vaccines meet 100 million uncertain Americans
Article
COVID-19 vaccines meet 100 million uncertain Americans
-
Refueling the innovation engine in vaccines
Article
Refueling the innovation engine in vaccines
-

There are many aspects of the science, and of the public health and epidemiology literature, to consider, which we bring as a fact base to support meaningful decisions our clients make that impact people’s lives every single day.

Partner, Philadelphia
Video

Considering every aspect of society

Getting shots into arms: How US states are addressing the vaccine distribution challenge
Article
“Getting shots into arms”: How US states are addressing the vaccine distribution challenge
-
Rebuilding clinician mental health after COVID-19
Article
Rebuilding clinician mental health and well-being after COVID-19
-
Lieven Van der Veken

The biggest risk I see is inequity. Of course, we have certain populations and certain environments running ahead, as fast as they can, but in the end, nobody’s safe until everybody’s safe from the pandemic.

Senior Partner, Geneva
Video

Setting ambitious goals to address vaccine access

The COVID-19 vaccine: Lessons and challenges
Podcast
The COVID-19 vaccine: Lessons and challenges
-
Not the last pandemic: Investing now to reimagine public-health systems
Article
Not the last pandemic: Investing now to reimagine public-health systems
-

Related

Healthcare Systems & Services
How We Help Clients
Public & Social Sector
Pharmaceuticals and Medical Products